LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

ABBV

193.18

+0.34%↑

MRK

117.82

-0.52%↓

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

ABBV

193.18

+0.34%↑

MRK

117.82

-0.52%↓

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

ABBV

193.18

+0.34%↑

MRK

117.82

-0.52%↓

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

ABBV

193.18

+0.34%↑

MRK

117.82

-0.52%↓

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

ABBV

193.18

+0.34%↑

MRK

117.82

-0.52%↓

Home・Listă Acțiuni・Johnson and Johnson

Johnson and Johnson

Închisă

Sector Sănătate

164.37 -0.29

Cumpără Vinde

Rezumat

Modificarea prețului

24h

Curent

Minim

164.14

Maxim

164.71

Indicatori cheie
By Trading Economics
Venit	1.4B 4.7B
Vânzări	1.1B 22B
P/E Medie Sector	21.72 103.001
EPS	2.82
Marjă de profit	20.873
Angajați	131,900
EBITDA	2.1B 7.8B

Recomandări
By TipRanks
Recomandări	Cumpărare
Prognoză pe 12 luni	+4.92 upside

Dividende
By Dow Jones
Următoarele câștiguri	15 oct. 2024
Data viitoare de dividende	10 sept. 2024
Următoarea dată ex-dividende	18 nov. 2024

Statistici piață
By TradingEconomics
Capitalizare de piață	400B
Deschiderea anterioară	164.66
Închiderea anterioară	164.37

Sentimentul știrilor

By Acuity

55%

45%

293 / 365 Clasament în Healthcare

Scor tehnic

By Trading Central

Încredere

Strong Bearish Evidence

164.13 / 164.61 Suport & Rezistență

Johnson and Johnson Grafic

Știri relevante

20 aug. 2024, 12:16 UTC

Achiziții, Fuziuni, Preluări

Johnson & Johnson to Buy V-Wave for Upfront Payment of $600 Million

20 aug. 2024, 11:43 UTC

Top știri

Johnson & Johnson's Rybrevant, Lazcluze Combo Gets FDA Approval for Type of Advanced Lung Cancer

17 iul. 2024, 14:14 UTC

Câștiguri

Trending: Johnson & Johnson Beats 2Q Sales Guidance

4 sept. 2024, 23:20 UTC

Top știri

Johnson & Johnson Wins Over Longtime Holdout for Talc Settlement -- Update

23 aug. 2024, 20:54 UTC

Top știri

J&J Takes Aim at Hospital Drug-Discount Program -- Update

23 aug. 2024, 18:09 UTC

Top știri

J&J Takes Aim At Hospital Drug-Discount Program -- WSJ

20 aug. 2024, 12:41 UTC

Top știri

Achiziții, Fuziuni, Preluări

Johnson & Johnson Gets FDA Approval for Treatment, Makes Acquisition of Up to $1.7 Billion -- Barrons.com

20 aug. 2024, 12:01 UTC

Achiziții, Fuziuni, Preluări

Johnson & Johnson to Buy V-Wave for Upfront Payment of $600M

20 aug. 2024, 11:55 UTC

Achiziții, Fuziuni, Preluări

J&J To Acquire V-Wave For Up To $1.7 Billion In Play For Heart Failure Device -- MarketWatch

20 aug. 2024, 11:31 UTC

Achiziții, Fuziuni, Preluări

Johnson & Johnson Expects the Transaction to Dilute Adjusted EPS by 24c in 2024 and 6c in 2025 >JNJ

20 aug. 2024, 11:31 UTC

Achiziții, Fuziuni, Preluări

Johnson & Johnson Transaction Is Expected to Close Before the End of 2024 >JNJ

20 aug. 2024, 11:31 UTC

Achiziții, Fuziuni, Preluări

Johnson & Johnson Will Join Johnson & Johnson as Part of Johnson & Johnson MedTech >JNJ

20 aug. 2024, 11:31 UTC

Achiziții, Fuziuni, Preluări

Johnson & Johnson Will Acquire V-Wave for an Upfront Payment of $600M With the Potential for Additional Regulatory and Comml Milestone Payments Up to $1.1B >JNJ

20 aug. 2024, 11:30 UTC

Achiziții, Fuziuni, Preluări

Johnson & Johnson To Acquire V-Wave >JNJ

20 aug. 2024, 11:12 UTC

Top știri

Johnson & Johnson Wins First FDA Approval For Chemotherapy-Free Lung Cancer Treatment -- MarketWatch

12 aug. 2024, 14:30 UTC

Achiziții, Fuziuni, Preluări

Correction to Big Drugmakers Are Clinching Smaller Deals Article -- WSJ

12 aug. 2024, 09:30 UTC

Top știri

Achiziții, Fuziuni, Preluări

Big Drugmakers Are Clinching Smaller Deals -- WSJ

29 iul. 2024, 10:30 UTC

Top știri

Big Pharma Rallies and Moves Past Obesity -- Heard on the Street -- WSJ

17 iul. 2024, 11:24 UTC

Market Talk

Câștiguri

Achiziții, Fuziuni, Preluări

J&J Lifts Sales View But Lowers Earnings Outlook -- Market Talk

17 iul. 2024, 10:43 UTC

Câștiguri

Johnson & Johnson Earnings Top, But Dow Stock Falls On Lowered Guidance -- IBD

17 iul. 2024, 10:20 UTC

Câștiguri

Johnson & Johnson: MedTech Operational Sales Growth Expected to Accelerate in 2H >JNJ

17 iul. 2024, 10:20 UTC

Câștiguri

Johnson & Johnson Cuts 2024 View To Adj EPS $9.97-Adj EPS $10.07 Vs Prior View $10.57-$10.72 >JNJ

17 iul. 2024, 10:20 UTC

Câștiguri

Johnson & Johnson Backs 2024 Adjusted Operational Sales Growth View of 5.5%-6% >JNJ

17 iul. 2024, 10:20 UTC

Câștiguri

Johnson & Johnson: 2Q MedTech Worldwide Operational Sales Growth Was Driven Primarily by Electrophysiology Products and Abiomed in Cardiovascular, and Wound Closure Products in General Surgery >JNJ

17 iul. 2024, 10:20 UTC

Câștiguri

Johnson & Johnson Backs 2024 Sales $88.0B-$88.4B >JNJ

17 iul. 2024, 10:20 UTC

Câștiguri

Johnson & Johnson Cuts 2024 Adjusted Operational EPS View to $10.00-$10.10 Vs Prior View $10.60-$10.75 >JNJ

17 iul. 2024, 10:20 UTC

Câștiguri

Johnson & Johnson: 2Q Innovative Medicine Worldwide Operational Sales, Excluding Covid Vaccine, Grew 8.8% >JNJ

17 iul. 2024, 10:20 UTC

Câștiguri

Johnson & Johnson Updating 2024 Guidance to Reflect Improved Performance and Impact for Recent Acquisitions of Shockwave Medical, Proteologix and NM26 Bispecific Antibody >JNJ

17 iul. 2024, 10:20 UTC

Câștiguri

Johnson & Johnson Raises 2024 Operational Sales View to $89.2B-$89.6B Vs Prior View $88.7B-$89.1B >JNJ

17 iul. 2024, 10:20 UTC

Câștiguri

Johnson & Johnson 2Q Worldwide MedTech Sales $7.96B >JNJ

Comparație

Modificare preț

Johnson and Johnson Așteptări

Obiectiv de preț

By TipRanks

4.92% sus

Prognoză pe 12 luni

Medie 172.46 USD 4.92%

Maxim 215 USD

Minim 150 USD

În baza a 14 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruJohnson and Johnson - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Cumpărare

14 ratings

Cumpărare

Păstrare

Vânzare

Ținând cont de 14 analiști care au acordat evaluări ale acțiunilor Johnson and Johnson - Dist în ultimele 3 luni.

Scor tehnic

By Trading Central

164.13 / 164.61Suport & Rezistență

Recent bearish events outweigh bullish events.

All events are bullish.

Recent bullish events outweigh bearish events.

Sentiment

By Acuity

293 / 365 Clasament în Sănătate

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

Despre Johnson and Johnson

Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being. The Consumer segment includes a range of products used in the skin health/beauty, over-the-counter medicines, baby care, oral care, women’s health and wound care markets. The Pharmaceutical segment is focused on six immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism and pulmonary hypertension. The Medical Devices segment includes a range of products used in the interventional solutions, orthopedic, surgery, and vision fields.